BioSpace News Archive

FDA

Merck Receives Breakthrough Therapy Designation from FDA for V114, the Company’s Investigational 15-Valent Conjugate Vaccine for the Prevention of Invasive Pneumococcal Disease, in Infants, Children, and Adolescents

Merc that V114 has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration for the prevention of invasive pneumococcal disease caused by the vaccine serotypes in pediatric patients 6 weeks to 18 years of age.

January 30, 2019
·
5 min read
Business

Lannett To Report Fiscal 2019 Second-Quarter Financial Results, Host Conference Call On Wednesday, February 6

Lannett Company, Inc. announced that it will report financial results for its fiscal 2019 second quarter on Wednesday, February 6, 2019, after the market closes.

January 30, 2019
·
1 min read
It’s Bell Let’s Talk Day! Join the world’s biggest mental health conversation as we get ready to achieve some major milestones

All-time Bell Let’s Talk Day messages of support set to top a total of 1 billion this year; Bell’s total funding commitment to surpass $100 million

January 30, 2019
·
12 min read
Business

Irene Birbeck Promoted to Partner with Clarkston Consulting

Consumer products and life sciences consulting leader Clarkston Consulting announced the promotion of Irene Birbeck to Partner.

January 30, 2019
·
2 min read
Biotech Beach

CardioVax Announces Name Change to Abcentra

Reflects Strategic Commitment to a Novel Drug Target for Inflammatory Disease

January 30, 2019
·
3 min read
Deals

Livongo Signs Definitive Agreement to Acquire myStrength to Address Behavioral Health Needs for People with Chronic Conditions

Acquisition Positions Livongo to Address the Health of the Whole Person

January 30, 2019
·
6 min read
Genetown

EPS Corporation Selects 4G Clinical as IRT/RTSM Provider for Multinational Clinical Trials

Strategic Partnership Aims to Accelerate Clinical Trials World-Wide

January 30, 2019
·
2 min read
Policy

Sigilon Therapeutics Expands Intellectual Property Portfolio with New Patent Issued

Portfolio Covers 16 Patent Families Across Major Markets

January 30, 2019
·
2 min read
Job Trends

Castle Biosciences Announces Publication of Prospective Multicenter Study Demonstrating that its DecisionDx-Melanoma Test can Inform Sentinel Lymph Node Biopsy Decisions

Validation data from 1,421 patients published in Future Oncology

January 30, 2019
·
5 min read
Can-Fite’s Drugs’ Potential Ability to Treat Cytokine Release Syndrome in Cancer Immunotherapy Published in Scientific Journal

Can Fite’s drugs robustly inhibit the release of inflammatory mediators that induce Cytokine Release Syndrome (CRS), a potentially fatal side effect of CAR-T and other immune-oncology therapies

January 30, 2019
·
6 min read